Management of fungal diseases.
Diseases caused by the normally pathogenic fungi are common. The vast majority of patients will not require treatment. Amphotericin B remains the gold standard when treatment is needed. The availability of ketoconazole has provided an alternative mode of therapy, but its exact place is not yet defined.
D001759:Blastomycosis / Q000188:drug therapy; D003047:Coccidioidomycosis / Q000188:drug therapy; D003168:Complement Fixation Tests; D006660:Histoplasmosis / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007654:Ketoconazole; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D010879:Piperazines / Q000627:therapeutic use; D014481:United States
D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole